157 related articles for article (PubMed ID: 37342994)
1. Mechanistic Evaluations of the Effects of Auranofin Triethylphosphine Replacement with a Trimethylphosphite Moiety.
Ronga L; Tolbatov I; Giorgi E; Pisarek P; Enjalbal C; Marrone A; Tesauro D; Lobinski R; Marzo T; Cirri D; Pratesi A
Inorg Chem; 2023 Jul; 62(26):10389-10396. PubMed ID: 37342994
[TBL] [Abstract][Full Text] [Related]
2. Chemical Modification of Auranofin Yields a New Family of Anticancer Drug Candidates: The Gold(I) Phosphite Analogues.
Cirri D; Geri A; Massai L; Mannelli M; Gamberi T; Magherini F; Becatti M; Gabbiani C; Pratesi A; Messori L
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770719
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, chemical characterization, and biological evaluation of a novel auranofin derivative as an anticancer agent.
Cirri D; Massai L; Giacomelli C; Trincavelli ML; Guerri A; Gabbiani C; Messori L; Pratesi A
Dalton Trans; 2022 Sep; 51(35):13527-13539. PubMed ID: 36000524
[TBL] [Abstract][Full Text] [Related]
4. Structural and solution chemistry, antiproliferative effects, and serum albumin binding of three pseudohalide derivatives of auranofin.
Cirri D; Fabbrini MG; Massai L; Pillozzi S; Guerri A; Menconi A; Messori L; Marzo T; Pratesi A
Biometals; 2019 Dec; 32(6):939-948. PubMed ID: 31686259
[TBL] [Abstract][Full Text] [Related]
5. Seleno-auranofin (Et3PAuSe-tagl): synthesis, spectroscopic (EXAFS, 197Au Mössbauer, 31P, 1H, 13C, and 77Se NMR, ESI-MS) characterization, biological activity, and rapid serum albumin-induced triethylphosphine oxide generation.
Hill DT; Isab AA; Griswold DE; DiMartino MJ; Matz ED; Figueroa AL; Wawro JE; DeBrosse C; Reiff WM; Elder RC; Jones B; Webb JW; Shaw CF
Inorg Chem; 2010 Sep; 49(17):7663-75. PubMed ID: 20704360
[TBL] [Abstract][Full Text] [Related]
6. Gold Nanoclusters as Nanoantibiotic Auranofin Analogues.
Ndugire W; Raviranga NGH; Lao J; Ramström O; Yan M
Adv Healthc Mater; 2022 May; 11(9):e2101032. PubMed ID: 34350709
[TBL] [Abstract][Full Text] [Related]
7. The electrochemical profiles of Auranofin and Aubipy
Kupiec M; Ziółkowski R; Massai L; Messori L; Pawlak K
J Inorg Biochem; 2019 Sep; 198():110714. PubMed ID: 31170580
[TBL] [Abstract][Full Text] [Related]
8. A complex bearing TSPO PIGA ligand coordinated to the [Au(PEt
Chiaverini L; Baglini E; Mannelli M; Poggetti V; Da Settimo F; Taliani S; Gamberi T; Barresi E; La Mendola D; Marzo T
Biometals; 2023 Oct; 36(5):961-968. PubMed ID: 36869967
[TBL] [Abstract][Full Text] [Related]
9. Gold-Based Metal Drugs as Inhibitors of Coronavirus Proteins: The Inhibition of SARS-CoV-2 Main Protease by Auranofin and Its Analogs.
Massai L; Grifagni D; De Santis A; Geri A; Cantini F; Calderone V; Banci L; Messori L
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421689
[TBL] [Abstract][Full Text] [Related]
10. (13)C, (31)P and (15)N NMR studies of the ligand exchange reactions of auranofin and chloro(triethylphosphine)gold(I) with thiourea.
Ahmad S; Isab AA
J Inorg Biochem; 2002 Jan; 88(1):44-52. PubMed ID: 11750024
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships in a series of auranofin analogues showing remarkable antiproliferative properties.
Landini I; Massai L; Cirri D; Gamberi T; Paoli P; Messori L; Mini E; Nobili S
J Inorg Biochem; 2020 Jul; 208():111079. PubMed ID: 32497830
[TBL] [Abstract][Full Text] [Related]
12. Anticancer Agents: Does a Phosphonium Behave Like a Gold(I) Phosphine Complex? Let a "Smart" Probe Answer!
Ali M; Dondaine L; Adolle A; Sampaio C; Chotard F; Richard P; Denat F; Bettaieb A; Le Gendre P; Laurens V; Goze C; Paul C; Bodio E
J Med Chem; 2015 Jun; 58(11):4521-8. PubMed ID: 25973667
[TBL] [Abstract][Full Text] [Related]
13. Bioconjugation of Cyclometalated Gold(III) Lipoic Acid Fragments to Linear and Cyclic Breast Cancer Targeting Peptides.
Śmiłowicz D; Slootweg JC; Metzler-Nolte N
Mol Pharm; 2019 Nov; 16(11):4572-4581. PubMed ID: 31596097
[TBL] [Abstract][Full Text] [Related]
14. Micelles based on gold-glycopolymer complexes as new chemotherapy drug delivery agents.
Pearson S; Scarano W; Stenzel MH
Chem Commun (Camb); 2012 May; 48(39):4695-7. PubMed ID: 22473015
[TBL] [Abstract][Full Text] [Related]
15. Breast Cancer Treatment: The Case of Gold(I)-Based Compounds as a Promising Class of Bioactive Molecules.
Galassi R; Luciani L; Wang J; Vincenzetti S; Cui L; Amici A; Pucciarelli S; Marchini C
Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053228
[TBL] [Abstract][Full Text] [Related]
16. Auranofin and its Analogues Show Potent Antimicrobial Activity against Multidrug-Resistant Pathogens: Structure-Activity Relationships.
Marzo T; Cirri D; Pollini S; Prato M; Fallani S; Cassetta MI; Novelli A; Rossolini GM; Messori L
ChemMedChem; 2018 Nov; 13(22):2448-2454. PubMed ID: 30252208
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of thionato(triethylphosphine) gold(I) complexes:analogues of "auranofin," an antiarthritic drug.
Isab AA; Shaw CF
J Inorg Biochem; 1990 Feb; 38(2):95-100. PubMed ID: 1969932
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative Properties of a Few Auranofin-Related Gold(I) and Silver(I) Complexes in Leukemia Cells and their Interferences with the Ubiquitin Proteasome System.
Cirri D; Schirmeister T; Seo EJ; Efferth T; Massai L; Messori L; Micale N
Molecules; 2020 Sep; 25(19):. PubMed ID: 32998355
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic auranofin analogues bearing phosphine, arsine and stibine ligands: A study on the possible role of the ligand on the biological activity.
Giorgi E; Mannelli M; Gamberi T; Durante M; Gabbiani C; Cirri D; Pratesi A
J Inorg Biochem; 2024 Feb; 251():112452. PubMed ID: 38070433
[TBL] [Abstract][Full Text] [Related]
20. Protein Metalation by Medicinal Gold Compounds: Identification of the Main Features of the Metalation Process through ESI MS Experiments.
Geri A; Massai L; Messori L
Molecules; 2023 Jul; 28(13):. PubMed ID: 37446857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
